SureTrader
Home > Boards > US Listed > Biotechs > Argos Therapeutics, Inc. (ARGS)

They sell the stock through proxies.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
TheShadow Member Profile
Member Level 
Followed By 37
Posts 1,984
Boards Moderated 1
Alias Born 09/16/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 4/19/2018 8:06:11 AM
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives GlobeNewswire Inc. - 4/19/2018 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/2/2018 5:09:06 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/2/2018 2:16:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2018 9:49:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2018 8:46:16 AM
Argos Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights GlobeNewswire Inc. - 4/2/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/30/2018 5:15:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/30/2018 5:14:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/30/2018 5:13:37 PM
Argos Therapeutics to Report Fourth Quarter and Year-End 2017 Financial Results and Operational Highlights on Monday, April ... GlobeNewswire Inc. - 3/28/2018 5:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/7/2018 4:34:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2018 8:31:12 AM
Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy GlobeNewswire Inc. - 2/15/2018 8:30:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 2/14/2018 4:59:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/5/2018 5:00:23 PM
Argos Obtains Option to License PD1 Checkpoint Inhibitors GlobeNewswire Inc. - 2/5/2018 4:47:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/2/2018 5:23:26 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 1/30/2018 4:31:40 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 1/25/2018 6:01:40 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/18/2018 1:21:28 PM
Argos Announces One-for-Twenty Reverse Stock Split GlobeNewswire Inc. - 1/18/2018 8:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 1/17/2018 11:16:32 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 1/17/2018 11:14:44 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 1/17/2018 11:12:03 AM
TheShadow Member Level  Wednesday, 01/03/18 04:28:40 PM
Re: declaes post# 1228
Post # of 1968 
They sell the stock through proxies.
Quote:
Argos today also reported that it has raised approximately $6.8 million of net proceeds under its at-the-market stock issuance facility with Cowen & Company



https://ih.advfn.com/p.php?pid=nmona&article=76181118


Who knows what evil lurks in the hearts of men?
The Shadow Knows!


my posts are my opinion, not to be advice.......
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist